215 related articles for article (PubMed ID: 31027700)
41. Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.
Patel RA; Coleman I; Roudier MP; Konnick EQ; Hanratty B; Dumpit R; Lucas JM; Ang LS; Low JY; Tretiakova MS; Ha G; Lee JK; True LD; De Marzo AM; Nelson PS; Morrissey C; Pritchard CC; Haffner MC
Cancer Res Commun; 2022 May; 2(5):277-285. PubMed ID: 36337169
[TBL] [Abstract][Full Text] [Related]
42. Wild-Type Anaplastic Lymphoma Kinase Expression in Solitary Pulmonary Nodules: A Potential Marker for Primary Lung Squamous Cell Carcinoma in Patients With Previous Neck Squamous Cell Carcinoma.
Takanashi Y; Shinmura K; Sekihara K; Ishikawa R; Funai K
Cureus; 2024 Apr; 16(4):e58051. PubMed ID: 38738001
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel
Li B; Jia Z; Huang Z; Xue J; Wang Y; Guo C; Si X; Chen Z; Li J; Chen R; Bie Z; De Giglio A; Christopoulos P; Liang N; Li S
Transl Lung Cancer Res; 2023 Nov; 12(11):2322-2329. PubMed ID: 38090526
[TBL] [Abstract][Full Text] [Related]
44. Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib.
Zhou Y; Hurtado-Castillo M; Pandey O
Front Med (Lausanne); 2023; 10():1288849. PubMed ID: 38093982
[TBL] [Abstract][Full Text] [Related]
45. Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report.
Zhang XY; Li J; Chen SL; Li Y; Wang H; He JH
Diagn Pathol; 2023 Aug; 18(1):97. PubMed ID: 37644531
[TBL] [Abstract][Full Text] [Related]
46. Comparing Genomic Profiles of
Xia W; Yang J; Li H; Li L; Liu J
Glob Med Genet; 2024 Jun; 11(2):175-186. PubMed ID: 38873557
[No Abstract] [Full Text] [Related]
47.
Conde E; Hernandez S; Rodriguez Carrillo JL; Martinez R; Alonso M; Curto D; Jimenez B; Caminoa A; Benito A; Garrido P; Clave S; Arriola E; Esteban-Rodriguez I; De Castro J; Sansano I; Felip E; Rojo F; Dómine M; Abdulkader I; Garcia-Gonzalez J; Teixido C; Reguart N; Compañ D; Insa A; Mancheño N; Palanca S; Juan-Vidal O; Baixeras N; Nadal E; Cebollero M; Calles A; Martin P; Salas C; Provencio M; Aranda I; Massuti B; Lopez-Vilaro L; Majem M; Paz-Ares L; Lopez-Rios F
JTO Clin Res Rep; 2024 Apr; 5(4):100653. PubMed ID: 38525319
[TBL] [Abstract][Full Text] [Related]
48. Practical challenges in lung cancer pathology: bedside care to treatment decisions.
Takano AM; Chow CY; Lim KH
Curr Opin Pulm Med; 2024 Jan; 30(1):48-57. PubMed ID: 37937545
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.
Mino-Kenudson M
Transl Lung Cancer Res; 2017 Oct; 6(5):570-587. PubMed ID: 29114473
[TBL] [Abstract][Full Text] [Related]
50. [ALK positive histiocytosis with multiple system involvement: report of a case].
Yao S; Zhang F; Chen Y; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):495-497. PubMed ID: 38678335
[TBL] [Abstract][Full Text] [Related]
51. The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer.
Osakabe M; Yamada N; Sugimoto R; Uesugi N; Nakao E; Honda M; Yanagawa N; Sugai T
Virchows Arch; 2024 Mar; ():. PubMed ID: 38512505
[TBL] [Abstract][Full Text] [Related]
52. Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients.
Metro G; Giannarelli D; Sidoni A; Chiari R; Bellezza G
Int J Biol Markers; 2018 Apr; ():1724600818754763. PubMed ID: 29683065
[No Abstract] [Full Text] [Related]
53. Low level ALK FISH positive results should be approached with caution and confirmed by an orthogonal method.
Toruner GA
Transl Lung Cancer Res; 2023 Jul; 12(7):1361-1363. PubMed ID: 37577303
[No Abstract] [Full Text] [Related]
54. Rediscovering immunohistochemistry in lung cancer.
La Salvia A; Meyer ML; Hirsch FR; Kerr KM; Landi L; Tsao MS; Cappuzzo F
Crit Rev Oncol Hematol; 2024 May; 200():104401. PubMed ID: 38815876
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemistry of Lung Cancer Biomarkers.
Beasley MB
Adv Anat Pathol; 2024 Apr; ():. PubMed ID: 38666761
[TBL] [Abstract][Full Text] [Related]
56. Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components.
Soundararajan R; Viscuse P; Pilie P; Liu J; Logotheti S; Laberiano Fernández C; Lorenzini D; Hoang A; Lu W; Soto LMS; Wistuba II; Xu M; Song X; Shepherd PDA; Navone NM; Tidwell RSS; Lozano G; Logothetis C; Zhang J; Long JP; Estecio MR; Tzelepi V; Aparicio AM
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35805010
[TBL] [Abstract][Full Text] [Related]
57. Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib.
Hu L; Xie Y; Zhao H
Pulmonology; 2024 Feb; ():. PubMed ID: 38402122
[No Abstract] [Full Text] [Related]
58. Response to "NGS, the New Global Standard?".
Ou SI; Hong JL; Christopoulos P; Lin HM; Vincent S; Churchill EN; Soeda J; Kazdal D; Thomas M; Stenzinger A
J Thorac Oncol; 2023 Oct; 18(10):e116-e118. PubMed ID: 37758351
[No Abstract] [Full Text] [Related]
59. Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance.
Zugazagoitia J; Gómez-Rueda A; Jantus-Lewintre E; Isla D; Camps C; Ramos I; Trigo JM; Bernabé R; Juan-Vidal O; Sanchez-Torres JM; García-Campelo R; Provencio M; Felip E; de Castro J; Faull I; Lanman RB; Ponce-Aix S; Paz-Ares L; Garrido P
Lung Cancer; 2019 Aug; 134():72-78. PubMed ID: 31319999
[TBL] [Abstract][Full Text] [Related]
60. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
